Esophageal cancer related gene-4 inhibits the migration and proliferation of oral squamous cell carcinoma through BC200 lncRNA/MMP-9 and -13 signaling pathway

Cell Signal. 2019 Oct:62:109327. doi: 10.1016/j.cellsig.2019.05.012. Epub 2019 May 29.

Abstract

Esophageal cancer related gene-4 (ECRG4) inhibits the malignant phenotype of oral squamous cell carcinoma. However, the molecular mechanisms remain to be explored. Using the tongue carcinoma cell line, TCA8113 as a cell model, we showed that forced expression of ECRG4 down-regulated the expression of the BC200 long non-coding RNA (lncRNA) and matrix metalloproteinases (MMP-9 and MMP-13). Restoration of BC200 lncRNA rescued ECRG4-mediated down-regulation of MMP-9 and -13. Furthermore, over-expression of Ecrg4 inhibited cell proliferation and migration, which was abolished by forced expression of BC200 lncRNA in TCA8113 cells. Our results indicate that ECRG4 inhibits the malignant phenotype of TCA8113 cells most likely through suppression of BC200 lncRNA/MMPs signaling pathway, rationalizing that BC200 lncRNA may be a potential target for oral squamous cell carcinoma (OSCC) therapy.

Keywords: BC200 lncRNA; Cell migration; Cell proliferation; Esophageal cancer related gene-4; MMPs; Tumor suppressor gene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / pathology
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation / genetics
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • Matrix Metalloproteinase 13 / genetics
  • Matrix Metalloproteinase 9 / genetics
  • Mouth Neoplasms / genetics*
  • Mouth Neoplasms / pathology
  • RNA, Long Noncoding / genetics*
  • Signal Transduction / genetics
  • Tumor Suppressor Proteins / genetics*

Substances

  • ECRG4 protein, human
  • RNA, Long Noncoding
  • Tumor Suppressor Proteins
  • long non-coding RNA BC200, human
  • Matrix Metalloproteinase 13
  • Matrix Metalloproteinase 9